US Patent Issued to Think Therapeutics on Dec. 2 for "Multiplexed testing of lymphocytes for antigen specificity" (Massachusetts Inventors)

ALEXANDRIA, Va., Dec. 2 -- United States Patent no. 12,486,501, issued on Dec. 2, was assigned to Think Therapeutics Inc. (Newton, Mass.).

"Multiplexed testing of lymphocytes for antigen specificity" was invented by David Gifford (Newton, Mass.) and Brandon Carter (Cambridge, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein is a method for determining a lymphocyte cell receptor chain sequence specific to a unique antigen, comprising: sorting a plurality of antigens into a plurality of reaction mixtures, wherein the sorting comprises adding a unique antigen of the plurality of antigens to a unique subset of the plurality of reaction mixtures such that two different unique antigens are not...